Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added and the previous v3.5.0 tag was removed, indicating an administrative update to the study record's revision history. This update does not affect study data, eligibility criteria, or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-27T19:32:47.000Z thumbnail image
  2. Check
    17 days ago
    No Change Detected
  3. Check
    38 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was updated to Naples, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:09:36.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    The website revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T12:32:36.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Layout/UI updates were observed on the Study Details page. Core study information such as eligibility criteria, outcomes, and locations remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-28T05:59:29.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer, representing a minor version bump with no other visible changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T15:37:16.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page shows revision history updated from v3.4.0 to v3.4.1, with no visible changes to study details, layout, or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:10.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.